The Mechanistic Biology of Primary Immunodeficiency Disorders

2,500 participants · First posted Jan 9, 2018

Diagnostic Immunization With Rabies Vaccine in Patients With PID

40 participants · First posted Jul 7, 2015

Multivirus-specific Cytotoxic T Lymphocytes (mCTL)

1 participants · First posted Jul 29, 2015

ALTO-102 + ALTO-103 + ALTO-104

intravenous immunoglobulin (primary immunodeficiency disease)

PS-778629

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

AbbVie CDR (CAD Hedged)

United States

Vanda Pharmaceuticals

United States

EMA Validates Marketing Authorization Application for Mavorixafor in WHIM Syndrome Treatment

Quince Therapeutics' EryDex Phase 3 Trial for Ataxia-Telangiectasia Nears Enrollment Completion

Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency